PTC Therapeutics | Omløpsmidler

Current Assets Endring Dato
Acadia Pharmaceuticals USD 675.3M 59.17M 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Amgen USD 28.03B 2.3B 2024-03
Biogen USD 6.76B 103.1M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Cytokinetics USD 638.7M 10.65M 2024-03
Daiichi Sankyo JPY 2.12T 593.84B 2023-12
Gilead Sciences USD 14.04B 2.41B 2024-03
Incyte USD 4.85B 203.69M 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
Ironwood Pharmaceuticals USD 208.17M 25.11M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
PTC Therapeutics USD 1.17B 49.89M 2024-03
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
TG Therapeutics USD 360.58M 41.47M 2024-03
Ultragenyx Pharmaceutical USD 595.97M 3.22M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03
Xencor USD 562.25M 60.91M 2024-03



PTC Therapeutics Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.